NTP42:KVA4

· ATXA Therapeutics Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NTP42:KVA4, covering 2024-07-22 to 2024-07-22. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Pharmacokinetics (PK) and Relative Bioavailability of NTP42:KVA4 as a Solid Oral Dose [Phase 1]